<DOC>
	<DOCNO>NCT02223221</DOCNO>
	<brief_summary>Recurrent pregnancy loss ( RPL ) multifactorial disorder affect 1 % couple challenge patient clinician technically emotionally . IVF clinic see high prevalence RPL , since many RPL patient seek assist reproduction treatment without infertile factor . Guidelines evaluation treatment RPL patient include screen uterine abnormality , parental chromosome , autoimmune antibody cure gynecological infection , still half RPL patient remain unexplained . The documented high incidence chromosomal error first-trimester miscarriage increase rate aneuploidy patient RPL lead theory screen embryos implantation aneuploidy may decrease risk subsequent loss serve possible treatment . The technology , indication use , even terminology genetic test embryo greatly change since first PGD ( pre-implantation genetic diagnosis ) baby born 1990 . The current best evidence show blastocyst biopsy follow new rapid comprehensive chromosome screening ( term pre-implantation chromosomal screen comprehensive chromosome screening , PCS CCS , investigator generally term PGS ) base array-comprehensive genome hybridization ( aCGH ) , single nucleotide polymorphism array ( SNP-array ) next generation sequencing ( NGS ) , powerful technology . However , PGS technique suitable achieve improve clinical outcome yet identify well define , ITT base research carefully select control adequate sample size . The investigator research determine whether vitro fertilization ( IVF ) / intracytoplasmic sperm injection ( ICSI ) combine SNP-array base pre-implantation comprehensive chromosome screening ( CCS ) improve clinical outcome infertile female patient recurrent spontaneous abortion history .</brief_summary>
	<brief_title>Effects PGS Infertile Female Patients With RPL</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Female</mesh_term>
	<mesh_term>Abortion , Habitual</mesh_term>
	<criteria>Women 1848 year age schedule IVF ICSI history recurrent spontaneous abortion ( continous miscarriage occur earlier 20 week gestation equal great 2 time ) IVF institute meeting follow criterion : 1. regular menstrual cycle normal level E2 , P , FSH , LH , T , RPL early follicular phase ; 2. history hormone medicine application last 3 month ; 3. history poison contact ; 4. normal uterine adnexal ultrasonography ; 5 . TORCH ( ) , chlamydia ( ) , mycoplasma ( ) , normal leucorrhoea routine , antiphospholipid antibody ( ) , antinuclear antibody ( ) ; 6. couple , blood type incompatibility ABO antibody IgG≤1：64 normal blood chromosome analysis . 1. hydrosalpinx without operation ; endometriosis ; polycystic ovary syndrome ; adenomyosis ; uterine leiomyomata ( submucous myoma nonsubmucous myoma size exceed 4cm and/or compress endometrium ) ; uterine cavity lesion ( uterine malformation , intrauterine adhesion , septate uterus , endometritis etc ) ; 2. former abortion luteal phase defect without treatment ; 3. thyroid dysfunction increase CA125 level ; 4. acute inflammation genitourinary system STD carrier ; 5. unable comply study procedure .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>In Vitro Fertilization</keyword>
	<keyword>Intracytoplasmic Sperm Injections</keyword>
	<keyword>Infertility , Female</keyword>
	<keyword>Abortion , Habitual</keyword>
	<keyword>recurrent pregnancy loss</keyword>
	<keyword>comprehensive chromosome screening</keyword>
	<keyword>preimplantation genetic screening</keyword>
	<keyword>SNP array</keyword>
</DOC>